Tissue Regenix Group

Tissue Regenix Group is an international medical technology company specializing in regenerative medicine products derived from human allografts and animal (porcine) xenografts. The company operates from two primary locations: San Antonio, Texas (formerly CellRight Technologies) and Leeds, UK. The San Antonio facility processes, stores, and distributes Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P) to hospitals and medical professionals. It holds AATB accreditation and FDA registration, and complies with FDA requirements, AATB standards, and international regulations. The Leeds facility manufactures porcine tissue-based medical devices and serves as the corporate and R&D hub. The company's proprietary platform technologies—dCELL® and BioRinse™—are complementary bone and soft tissue processing platforms designed to enhance patient outcomes in regenerative medicine. Key products include the OrthoPure® XT Ligament Reconstruction Implant. The company is ISO 13485:2016 certified at its Leeds manufacturing site and focuses on transforming patient care in orthopedics, wound healing, and tissue regeneration through tissue engineering and allografts/xenografts processing.